ESR1 and neoplasm: The ER/PR-positive group obtained activated metabolism-related pathways and inhibited immune-related pathways (Figure 8B); compared to those of the opposite group, the metabolism-related pathways in the tumor tissues of the ER/PR-positive patients were significantly activated, while the immune-related pathways in the tumor tissues of ER/PR-negative patients were significantly activated.